Microbiology: Vitamin C kills tuberculosis bacteria
Nature Communications
May 22, 2013
Vitamin C preferentially kills Mycobacterium tuberculosis cells in the laboratory, reports a paper published in Nature Communications this week. Tuberculosis chemotherapy is lengthy and often not successful, particularly when the infection is caused by antimicrobial resistant strains. This work implies that supplementation of tuberculosis therapy with vitamin C may be beneficial as has been suggested in scientific reports published as early as the 1930s.
Bill Jacobs and colleagues show that, in comparison to other bacterial pathogens, M. tuberculosis is uniquely sensitive to vitamin C which kills the cells when in laboratory conditions. They find that the ability of vitamin C to kill the bacteria is due to the generation of reactive oxygen species within the bacterial cells and that the effect is evident in both antibiotic sensitive and resistant cells.
The researchers suggest that further research should be conducted to explore the potential of using vitamin C in tuberculosis chemotherapy.
doi: 10.1038/ncomms2898
Research highlights
-
Jun 30
Genomics: Gray wolf genome hints at dual ancestry of dogsNature
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 30
Microbiology: Transmission of gastrointestinal viruses in salivaNature
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports